Subscribe

Mary Beth Nierengarten

Articles by Mary Beth Nierengarten

Doublet Chemo Proves Superior to Single-agent Therapy in Older Patients with Advanced Non-small-cell Lung Cancer

ByMary Beth Nierengarten

August 9th 2010

Data from French trial should inform treatment decisions in the majority of lung cancer patients aged 70 and up.

Latest Updated Articles

Doublet Chemo Proves Superior to Single-agent Therapy in Older Patients with Advanced Non-small-cell Lung Cancer
Published: August 9th 2010 | Updated:

Trending on CGTlive®

CGTLive®’s Weekly Rewind – November 7, 2025

What Were the Most Significant Inflection Points or Breakthroughs in Cell and Gene Therapy?

© 2025 MJH Life Sciences^®

All rights reserved.